tVNS in Long COVID-19
NCT: NCT06585254 · ACTIVE_NOT_RECRUITING
Brief Summary
A prior open label study has shown that transcutaneous vagus nerve stimulation \[tVNS\] can improve the health of some patients with postacute sequelae of SARS-CoV-2 infection (PASC), severely affected enough to also fulfill criteria for myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS). The purpose of this study is to compare two sets of stimulus parameters to determine the one that best improves the health-related quality of life of these patients over a period of 6-weeks. Patients using their assigned device for at least 30 of the 42 possible opportunities will receive the best device for an additional 6-week period.
Frequently Asked Questions
What is tVNS in Long COVID-19?
tVNS in Long COVID-19 is a clinical trial registered under NCT06585254. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06585254?
The current status of NCT06585254 (tVNS in Long COVID-19) is: ACTIVE_NOT_RECRUITING.
When did tVNS in Long COVID-19 start?
tVNS in Long COVID-19 started on 2024-11-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.